MXPA03007722A - Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos. - Google Patents

Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos.

Info

Publication number
MXPA03007722A
MXPA03007722A MXPA03007722A MXPA03007722A MXPA03007722A MX PA03007722 A MXPA03007722 A MX PA03007722A MX PA03007722 A MXPA03007722 A MX PA03007722A MX PA03007722 A MXPA03007722 A MX PA03007722A MX PA03007722 A MXPA03007722 A MX PA03007722A
Authority
MX
Mexico
Prior art keywords
formula
group
compounds
phenyl
enantiomer
Prior art date
Application number
MXPA03007722A
Other languages
English (en)
Spanish (es)
Inventor
E Twyman Roy
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03007722A publication Critical patent/MXPA03007722A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03007722A 2001-02-27 2002-02-21 Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos. MXPA03007722A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
MXPA03007722A true MXPA03007722A (es) 2004-11-12

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007722A MXPA03007722A (es) 2001-02-27 2002-02-21 Compuestos de carbamato para usar en la prevencion o tratamiento de trastornos sicoticos.

Country Status (25)

Country Link
US (1) US6541513B2 (cg-RX-API-DMAC7.html)
EP (1) EP1401424B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276841B2 (cg-RX-API-DMAC7.html)
KR (1) KR100886578B1 (cg-RX-API-DMAC7.html)
CN (1) CN1262271C (cg-RX-API-DMAC7.html)
AR (1) AR032876A1 (cg-RX-API-DMAC7.html)
AT (1) ATE346597T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242296B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207829A (cg-RX-API-DMAC7.html)
CA (1) CA2439480C (cg-RX-API-DMAC7.html)
CZ (1) CZ302412B6 (cg-RX-API-DMAC7.html)
DE (1) DE60216457T2 (cg-RX-API-DMAC7.html)
DK (1) DK1401424T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275844T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303342A3 (cg-RX-API-DMAC7.html)
IL (2) IL157588A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007722A (cg-RX-API-DMAC7.html)
NO (1) NO20033801L (cg-RX-API-DMAC7.html)
NZ (1) NZ527991A (cg-RX-API-DMAC7.html)
PL (1) PL365021A1 (cg-RX-API-DMAC7.html)
PT (1) PT1401424E (cg-RX-API-DMAC7.html)
RS (1) RS51056B (cg-RX-API-DMAC7.html)
RU (1) RU2302240C2 (cg-RX-API-DMAC7.html)
TW (1) TWI251486B (cg-RX-API-DMAC7.html)
WO (1) WO2002067927A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2003007934A1 (en) 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MXPA03007720A (es) 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
DE60220043T2 (de) * 2001-02-27 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
JP2010508354A (ja) * 2006-10-31 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 広汎性発達障害の処置
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
WO2014142547A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
EP0480939B1 (en) * 1989-06-09 1995-01-25 The Upjohn Company Heterocyclic amines having central nervous system activity
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ302412B6 (cs) 2011-05-04
NO20033801D0 (no) 2003-08-26
CZ20032297A3 (cs) 2004-06-16
HUP0303342A3 (en) 2012-07-30
RS67503A (sr) 2006-12-15
DK1401424T3 (da) 2007-02-26
AU2002242296B2 (en) 2006-06-29
CN1505507A (zh) 2004-06-16
NZ527991A (en) 2005-04-29
JP2004523556A (ja) 2004-08-05
DE60216457D1 (de) 2007-01-11
RS51056B (sr) 2010-10-31
RU2003128983A (ru) 2005-03-10
US20020165272A1 (en) 2002-11-07
WO2002067927A1 (en) 2002-09-06
AR032876A1 (es) 2003-11-26
IL157588A0 (en) 2004-03-28
ES2275844T3 (es) 2007-06-16
KR100886578B1 (ko) 2009-03-05
PT1401424E (pt) 2007-02-28
RU2302240C2 (ru) 2007-07-10
ATE346597T1 (de) 2006-12-15
KR20030076713A (ko) 2003-09-26
HUP0303342A2 (hu) 2004-01-28
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
EP1401424A1 (en) 2004-03-31
DE60216457T2 (de) 2007-09-20
TWI251486B (en) 2006-03-21
US6541513B2 (en) 2003-04-01
NO20033801L (no) 2003-10-22
CN1262271C (zh) 2006-07-05
CA2439480C (en) 2011-04-26
PL365021A1 (en) 2004-12-27
BR0207829A (pt) 2004-06-22
IL157588A (en) 2009-12-24
CA2439480A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
KR101335941B1 (ko) 수면-각성 장애의 치료
US6541513B2 (en) Carbamate compounds for use in preventing or treating psychotic disorders
ES2284845T3 (es) Uso de un compuesto de carbamato para la prevencion y el tratamiento de enfermedades neurodegenerativas.
MXPA03007719A (es) Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos neurodegenerativos.
US20230201150A1 (en) The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
AU2005335241B2 (en) Methods for treating substance-related disorders
DE60210960T2 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
JP2004533415A (ja) 双極性障害の予防もしくは治療における使用のためのカルバメート化合物
EP4489741A1 (en) Compositions comprising meai and n-acylethanolamines and uses thereof
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
EP1408954B1 (en) Carbamate compounds for use in preventing or treating neuropathic pain
ES2285245T3 (es) Tratamiento de la disquinesia con 2,3-benzodiazapinas.

Legal Events

Date Code Title Description
FG Grant or registration